AstraZeneca blames trial design after Phase 3 hypophosphatasia study misses endpoint
AstraZeneca attributed the failure of its Phase 3 HICKORY trial for efzimfotase alfa to an imbalanced adult subgroup.
The front page of AI-driven biology
Thursday, October 15, 2026Thu, Oct 15
Updated 6:32 PM PT
AstraZeneca attributed the failure of its Phase 3 HICKORY trial for efzimfotase alfa to an imbalanced adult subgroup.
Researchers have adapted a video-segmentation foundation model, named ETSAM, to accurately map cell membranes within noisy 3D cryo-electron tomograms.
Researchers combined two deep-learning approaches to overcome light-induced damage and slow acquisition in RESOLFT super-resolution microscopy.
Computational biologists introduced NetMap, a software pipeline that jointly infers single-cell gene regulatory networks and clusters cell populations without needing pre-assigned cell annotations.
Researchers developed CHORUS, a deep-learning method that identifies binding interfaces on membrane proteins directly from raw amino acid sequences without requiring three-dimensional structures or evolutionary alignments.
Computational binder screening frequently filters candidates by predicted interface confidence, but a benchmark of 196 nanobody loop designs targeting the cancer protein survivin found no correlation between confidence metrics and actual epitope contact (rho = +0.100).
EpiDiff uses machine learning on DNA methylation data to produce a continuous numerical score of cellular differentiation across single-cell, sorted, and bulk tissue samples.
A team led by Scinetics introduced chain-of-structures, a framework that couples language reasoning with structural generative models to design enzymes directly from reaction specifications.
Researchers at Tsinghua University built PeTFlow, a generative flow-matching model that designs binding peptides directly within three-dimensional protein pockets.
FastaLake uses AlphaNovo de novo peptide predictions to retrieve complete microbial proteins from large catalogs, generating sample-specific search spaces that match or outperform traditional metagenomic databases.
Researchers deployed autonomous instances of Claude Code to search 1.9 billion protein clusters for reverse transcriptases, identifying a new class of giant-virus enzymes dubbed array-associated RTs.
A graph neural network called zPolaron designs functional proteins by modeling interactions between protein backbones and bound ligands alongside evolutionary patterns from ESM-2.
A machine learning tool called unduliner uses long-read sequencing data to connect specific somatic mutations with local changes in DNA methylation patterns.
A new evaluation framework named Cause-excluded Effect Evaluation exposes that previous single-cell target discovery benchmarks were inflated by data leakage and by leaking the target gene's own expression.
Researchers have introduced SpliceAI2, a deep learning model trained across multiple mammalian species that reconstructs full-length transcripts directly from DNA sequences.
Scientists measured the functional impact of 186,676 protein variants across 17 enzymes in the RAS-MAPK signaling cascade, generating 503,099 total cellular readouts.
Seal, a new transfer-learning framework, predicts spatiotemporal gene regulation and variant impacts across 26 brain regions, 30 cell types, and seven human developmental stages.
Researchers developed Droplet-MT, a microfluidic method that profiles the transcriptome and DNA methylation together across roughly 10,000 single cells per run.